Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.28 USD | +1.08% | -3.11% | -27.55% |
Evolution of the average Target Price on Amicus Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Amicus Therapeutics, Inc.
JPMorgan Chase | |
Morgan Stanley | |
UBS | |
BofA Securities | |
Goldman Sachs | |
BTIG | |
Berenberg Bank | |
SVB Leerink | |
Cantor Fitzgerald | |
Stifel Nicolaus | |
Chardan | |
Needham & Co. | |
J.P. Morgan Chase |
EPS Revisions
- Stock Market
- Equities
- FOLD Stock
- Consensus Amicus Therapeutics, Inc.